Back to Search Start Over

Desensitization in Iron Product Allergy.

Authors :
Di Girolamo A
Albanesi M
Loconte F
Di Bona D
Caiaffa MF
Macchia L
Source :
Acta haematologica [Acta Haematol] 2020; Vol. 143 (5), pp. 496-499. Date of Electronic Publication: 2020 Mar 17.
Publication Year :
2020

Abstract

Iron deficiency is the main cause of anemia in both sexes, with women being more commonly affected. Iron therapy is currently considered an effective and safe remedy to replenish the iron storages. Iron can be administrated both orally and intravenously. In particular, intravenous (IV) iron therapy is widely used when oral iron preparations are either not tolerated or ineffective. Indeed, IV iron improves iron stores more rapidly. Two main immunological responses have been described for iron hypersensitivity reactions (HSRs): IgE-mediated allergy and complement activation-related pseudo-allergy. Here, we report 3 cases of adult patients with iron allergy, who were successfully treated with two different desensitization procedures, respectively. Analysis of these cases demonstrates that, in the presence of HSRs to iron products, desensitization is an effective and safe procedure that prevents treatment discontinuation and hence allows therapeutic target achievement.<br /> (© 2020 S. Karger AG, Basel.)

Details

Language :
English
ISSN :
1421-9662
Volume :
143
Issue :
5
Database :
MEDLINE
Journal :
Acta haematologica
Publication Type :
Academic Journal
Accession number :
32182610
Full Text :
https://doi.org/10.1159/000503768